|
15/05/2024
|
Earnings brief: "1Q24: Beat on investment gain" – Neutral (TP Bt10)
|
|
29/02/2024
|
Earnings brief: "4Q23: Beat on VNB and EV with special DPS" – Neutral (TP Bt10)
|
|
15/11/2023
|
Earnings brief:
"
3Q23: Miss on higher ECL and resere"
– Neutral (TP Bt11)
|
|
15/08/2023
|
Earnings brief:
"2Q23: Decent results, as expected"
– Neutral (TP Bt12)
|
|
12/05/2023
|
Earnings brief:
"1Q23: Beat on investment gain"
– Neutral (TP Bt14)
|
|
24/02/2023
|
Earnings brief: "4Q22: Miss on ROI and EV" – Downgrade to Neutral (TP Bt14)
|
|
15/11/2022
|
Earnings brief: "3Q22: In line with expectations" – Outperform (TP Bt19)
|
|
29/08/2022
|
Initiate coverage: "Healthier and wealthier ahead" - Outperform (TP Bt19) |
| |
|
FOLLOW US
SCB's Facbook INVX's Twitter